1580
J. Witherington et al. / Bioorg. Med. Chem. Lett. 13 (2003) 1577–1580
9. Cross, D. A. E.; Culbert, A. A.; Chalmers, K. A.; Facci, L.;
References and Notes
Skaper, S. D.; Reith, A. D. J. Neurochem. 2001, 77, 94.
10. Klein, P. S.; Melton, D. A. Proc. Natl. Acad. Sci. U.S.A.
1996, 93, 8455.
11. (a) Aoki, M.; Iwamoto-Sugai, M.; Sugiura, I.; Sasaki, C.;
Hasegawa, T.; Okumura, C.; Sugio, S.; Kohno, T.; Matsuzaki,
T. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2000, D56,
1464. (b) Bax, B.; Carter, P. S.; Lewis, C.; Guy, A. R.; Bridges,
A.; Tanner, R.; Pettman, G.; Mannix, C.; Culbert, A. A.;
Brown, M. J. B.; Smith, D. G.; Reith, A. D. Structure (Lon-
don) 2001, 9, 1143.
12. Results are a mean of at least two determinations run in
duplicate (n=4) and are given as mean. MeanÆSEM are also
quoted for compounds of specific interest.
13. Davies, S. P.; Reddy, H.; Caivano, M.; Cohen, P. Bio-
chem. J. 2000, 351, 95.
1. Cohen, P.; Yellowlees, D.; Aitken, A.; Donella-Deana,
A.; Hemmings, B. A.; Parker, P. J. Eur. J. Biochem. 1982,
124, 21.
2. Woodgett, J. R. Trends Biochem. Sci. 1991, 16, 177.
3. (a) Leloir, L. F.; Olavaria, S. H.; Goldenberg, S. H.; Car-
minatti, H. Arch. Biochem. Biophys. 1959, 81, 508. (b) Man-
darino, L.; Wright, K.; Verity, L.; Nichols, J.; Bell, J.;
Kolterman, O.; Beck-Nielsen, H. J. Clin. Invest. 1987, 80, 655.
4. (a) Roach, P. FASEB J. 1990, 4, 2961. (b) Skurat, A. V.;
Roach, P. J. Biochem. J. 1996, 313, 45. (c) Zhang, W.;
DePaoli-Roach, A. A.; Roach, P. J. Arch. Biochem. Biophys.
1993, 304, 219. (d) Eldar-Finkelmann, H.; Argast, G. M.;
Foord, O.; Fischer, E. H.; Krebs, E. G. Proc. Natl. Acad. Sci.
U.S.A. 1996, 93, 10228.
5. DeFronzo, R. A.; Bonadonna, R. C.; Ferrannini, E. Dia-
betes Care 1992, 15, 318.
14. Using microtitre plates, GSK-3 was assayed in 50 mM
MOPS buffer, pH 7.0 containing 5% glycerol, 0.01% Tween-20,
7.5 mM 2-mercaptoethanol, 10 mM magnesium actetate, 8 mM
substrate peptide (Biotin - KYRRAAVPPSPSLSRHSSPHQ
(SP)EDEEE, where (SP) is a pre-phosphorylated serine) and
10 mM [g-33P]-ATP. After incubation for 1 h at room tem-
perature, the reaction was stopped by addition of 50 mM
EDTA solution containing Streptavidin coated SPA beads
(Amersham) to give a final 0.2 mg of beads per assay well in a
384 microtitre plates were counted in a trilux 1450 microbeta
liquid scintillation counter (Wallac).
6. (a) Thorburn, A. W.; Gumbiner, B.; Bulacan, F.; Wallace,
P.; Henry, R. R. J. Clin. Invest. 1990, 85, 522. (b) Beck-Niel-
sen, H.; Vaag, A.; Damsbo, P.; Handberg, A.; Neilsen, O. H.;
Henriksen, J. E.; Thye-Ronn, P. Diabetes Care 1992, 15, 418.
(c) Bogardus, C.; Lillioja, S.; Stone, K.; Mott, D. J. Clin.
Invest. 1984, 73, 1185.
7. Nikoulina, S. E.; Ciaraldi, T. P.; Mudaliar, S.; Carter, L.;
Johnson, K.; Henry, R. R. Diabetes 2002, 51, 2190.
8. Lovestone, S.; Reynolds, C. H.; Latimer, D.; Davis, D. R.;
Anderton, B. H.; Gallo, J.-M.; Hanger, D.; Mulot, S.; Mar-
quardt, B. Curr. Biol. 1994, 4, 1077.
15. All novel compounds gave satisfactory 1H NMR and LC/
MS data in full agreement with their proposed structures.